» Articles » PMID: 1894371

Specific and Nonspecific Antibody Responses in Different Segments of the Respiratory Tract in Rats Infected with Mycoplasma Pulmonis

Overview
Journal Infect Immun
Date 1991 Oct 1
PMID 1894371
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Murine respiratory mycoplasmosis resulting from Mycoplasma pulmonis infection in rats provides a useful model for the study of immunological and inflammatory mechanisms operative in the respiratory tract. We have previously shown that LEW rats develop more severe disease than do F344 rats. To further study the production of antibody responses in chronic respiratory disease due to M. pulmonis infection, we examined the distribution and development of M. pulmonis-specific antibody-forming cells (AFC) in different segments of the respiratory tracts of infected LEW and F344 rats. In these studies, the upper respiratory nodes were the initial site of antibody production after infection and remained the major site for recovery of AFC. Since infected LEW rats had equal or higher numbers of AFC than did infected F344 rats, these results suggest that the level of local antibody production alone is not responsible for the decreased susceptibility of F344 rats to murine respiratory mycoplasmosis. The differences in total antibody responses appear to be due to the greater numbers of cells recovered from the tissues of infected LEW rats compared with those recovered from F344 rats, suggesting that LEW rats may have greater production of chemotactic factors. Also, we demonstrate that nonspecific activation and/or recruitment of B cells occurs in the respiratory tracts of both LEW and F344 rats after infection with M. pulmonis.

Citing Articles

The Use of Bacteriophages and Immunological Monitoring for the Treatment of a Case of Chronic Septicemic Cutaneous Ulcerative Disease in a Loggerhead Sea Turtle Caretta caretta.

Greene W, Chan B, Bromage E, Grose J, Walsh C, Kortright K J Aquat Anim Health. 2021; 33(3):139-154.

PMID: 34216060 PMC: 8518602. DOI: 10.1002/aah.10130.


THE MULTIFACETED ROLE OF T CELL-MEDIATED IMMUNITY IN PATHOGENESIS AND RESISTANCE TO MYCOPLASMA RESPIRATORY DISEASE.

Dobbs N, Odeh A, Sun X, Simecka J Curr Trends Immunol. 2011; 10:1-19.

PMID: 21743780 PMC: 3131222.


Lung and splenic B cells facilitate diverse effects on in vitro measures of antitumor immune responses.

Jones H, Wang Y, Aldridge B, Weiss J Cancer Immun. 2008; 8:4.

PMID: 18281925 PMC: 2935774.


Immunoglobulin A (IgA) responses and IgE-associated inflammation along the respiratory tract after mucosal but not systemic immunization.

Hodge L, Marinaro M, Jones H, McGhee J, Kiyono H, Simecka J Infect Immun. 2001; 69(4):2328-38.

PMID: 11254590 PMC: 98162. DOI: 10.1128/IAI.69.4.2328-2338.2001.


Gene rearrangements in the vsa locus of Mycoplasma pulmonis.

Shen X, Gumulak J, Yu H, French C, Zou N, Dybvig K J Bacteriol. 2000; 182(10):2900-8.

PMID: 10781561 PMC: 102001. DOI: 10.1128/JB.182.10.2900-2908.2000.


References
1.
Taylor G, Howard C . Class-specific antibody responses to Mycoplasma pulmonis in sera and lungs of infected and vaccinated mice. Infect Immun. 1980; 29(3):1160-8. PMC: 551253. DOI: 10.1128/iai.29.3.1160-1168.1980. View

2.
Hayflick L . Tissue cultures and mycoplasmas. Tex Rep Biol Med. 1965; 23:Suppl 1:285+. View

3.
Naot Y, Ginsburg H . Activation of B lymphocytes by mycoplasma mitogen(s). Immunology. 1978; 34(4):715-20. PMC: 1457187. View

4.
Cassell G, Davis J . Protective effect of vaccination against Mycoplasma pulmonis respiratory disease in rats. Infect Immun. 1978; 21(1):69-75. PMC: 421959. DOI: 10.1128/iai.21.1.69-75.1978. View

5.
Shvartsman Y, Agranovskaya E, ZYKOV M . Formation of secretory and circulating antibodies after immunization with live and inactivated influenza virus vaccines. J Infect Dis. 1977; 135(5):697-705. DOI: 10.1093/infdis/135.5.697. View